123 related articles for article (PubMed ID: 3509487)
1. Carumonam in the treatment of severe and complicated urinary tract infections.
Kotilainen P; Huovinen P; Hänninen P
Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
[No Abstract] [Full Text] [Related]
2. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
[No Abstract] [Full Text] [Related]
3. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
Westenfelder M; Frankenschmidt A; Pelz K
Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
[No Abstract] [Full Text] [Related]
4. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
[TBL] [Abstract][Full Text] [Related]
6. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
7. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
9. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam versus cefamandole in the treatment of urinary tract infections.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo experience with carumonam: a preliminary report.
Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
[No Abstract] [Full Text] [Related]
12. Carumonam versus ceftazidime for urinary tract infections.
Edelstein H; Oster S; Cassano K; McCabe R
Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
[TBL] [Abstract][Full Text] [Related]
13. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A; Cortecchia V; Ventriglia L
Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
[No Abstract] [Full Text] [Related]
14. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
16. [Aztreonam in the treatment of nosocomial urinary infections].
Nardini A; Taddei P; Rossi F
G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
[No Abstract] [Full Text] [Related]
17. Effectiveness and tolerability of aztreonam in urinary tract infection caused by multiresistant bacteria.
Muzzonigro G; Minardi D; Caraceni E; Villanova A; Polito M
Acta Urol Belg; 1987; 55(3):485-90. PubMed ID: 3661329
[No Abstract] [Full Text] [Related]
18. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Hoepelman AI; Bakker LJ; Verhoef J
Antimicrob Agents Chemother; 1988 Apr; 32(4):473-6. PubMed ID: 3377459
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
[No Abstract] [Full Text] [Related]
20. [Rational antibiotic therapy of urinary tract infections].
Wagenlehner FM; Naber KG; Weidner W
Med Monatsschr Pharm; 2008 Oct; 31(10):385-90; quiz 391-2. PubMed ID: 18972869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
